The FINANCIAL — Teva Pharmaceutical Industries Ltd., on June 12 announced the launch of generic Zetia®1 (ezetimibe) tablets, 10 mg, in the U.S. Ezetimibe is a prescription medicine used to lower ...

In February, a federal judge said Merck & Co. and Glenmark Pharmaceuticals would have to face a jury trial over an alleged pay-for-delay deal on the cholesterol med Zetia. Now, a pair of plaintiff ...

CHICAGO--(BUSINESS WIRE)--If you are a Third-Party Payor which indirectly purchased, paid, or provided reimbursement for some or all of the price of brand Zetia or its AB-rated generic equivalents, ...

Kaiser Foundation Health Plans is suing Merck alleging anticompetitive behavior for delaying a generic version of its drug to enter the market, a practice known in the industry as "pay-for-delay." ...

Merck has been hit with an antitrust action in New Jersey federal court, which claimed that the company entered into an anti-competitive settlement agreement and an unlawful business arrangement in ...

MUMBAI, April 27 (Reuters) - India's Glenmark Pharmaceuticals Ltd's said on Monday its generics drugs unit has secured tentative approval from the U.S. Food and Drug Administration (FDA) to sell its ...

Reduce elevated total-C and LDL-C in patients with homozygous familial; hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatin; and Reduce elevated sitosterol and campesterol in ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

NEW YORK (Reuters Health) - Contrary to a recent report, findings from a large-scale study suggest that the cholesterol-lowering drug Zetia (also known by the generic name, ezetimibe) does not ...